New N-alkylated 1, 4-dihydropyridine derivatives were synthesized and their ability to overcome multidrug resistance was examined in vincristine-resistant P388 cells (P388/VCR cells). Compounds that possessed an arylalkyl substituent on the dihydropyridine ring nitrogen were more potent than verapamil in potentiating the cytotoxicity of vincristine against P388/VCR cells. However, neither drug effectively enhanced the antitumor activity of vincristine in tumor-bearing mice. Introduction of basic nitrogen-containing substituents on the side chain of 1, 4-dihydropyridines gave improved activity in vitro and in vivo. The piperazine derivative 12c and 12o were more than 10 times as potent as verapamil in vitro. Four compounds selected for in vivo testing showed superior antitumor activity in P388/VCR-bearing mice in combination with vincristine. The structure-activity relationships of the compounds are discussed.
新合成的N-烷基化1,4-二氢
吡啶衍生物,在
长春新碱耐药的P388细胞(P388/
VCR细胞)中检测了其克服多药耐药的能力。在
二氢吡啶环氮上带有芳烷基取代基的化合物,比
维拉帕米更能增强
长春新碱对P388/
VCR细胞的细胞毒性。然而,这两种药物均未有效地增强
长春新碱在携带肿瘤的小鼠中的抗肿瘤活性。在1,4-
二氢吡啶的侧链上引入含有碱性氮的取代基,在体外和体内均能提高活性。
哌嗪衍
生物12c和12o在体外比
维拉帕米强10倍以上。选出四种化合物进行体内测试,它们与
长春新碱联合使用时,在携带P388/
VCR的肿瘤小鼠中显示出优越的抗肿瘤活性。讨论了化合物的构效关系。